UB Paderborn / Katalog / Suche / in CDI

Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy

Seminars in oncology, 2010-10, Vol.37 (5), p.533-546

2010

Volltextzugriff (PDF)

Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data

The lancet oncology, 2017-01, Vol.18 (1), p.132-142

2017

Volltextzugriff (PDF)

Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis

The lancet oncology, 2017, Vol.18 (1), p.143-154

2017

Volltextzugriff (PDF)

Personality diversity in the workplace: A systematic literature review on introversion

Journal of workplace behavioral health, 2023-04, Vol.38 (2), p.165-187

2023

Volltextzugriff (PDF)

Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)

PloS one, 2017-02, Vol.12 (2), p.e0170544-e0170544

2017

Volltextzugriff (PDF)

Preparing for Responsible Sharing of Clinical Trial Data

The New England journal of medicine, 2014-01, Vol.370 (5), p.484-485

2014

Volltextzugriff (PDF)

Survival prediction using time-evolving tumor load: An approach to rationally design treatment sequencing, staging, and dosing strategies for oncology combinations

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20040-e20040

2017

Volltextzugriff (PDF)

The Prostate Cancer DREAM Challenge: A Community‐Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer

The oncologist (Dayton, Ohio), 2015-05, Vol.20 (5), p.459-460

2015

Volltextzugriff (PDF)

Model-based meta-analysis of safety for immune checkpoint inhibitor combinations and monotherapy

Journal of clinical oncology, 2017-03, Vol.35 (7_suppl), p.89-89

2017

Volltextzugriff (PDF)

Chronic rejection: Insights from a novel immunosuppressive-free model of kidney transplantation

Journal of the American Society of Nephrology, 2004-03, Vol.15 (3), p.687-694

2004

Volltextzugriff (PDF)

Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress

The cancer journal (Sudbury, Mass.), 2022-03, Vol.28 (2), p.151

2022

Volltextzugriff (PDF)

Project Data Sphere: A first look at prostate cancer including concomitant medication use, prognosis, and toxicity

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.5022-5022

2015

Volltextzugriff (PDF)

Dynamic predictions of patient survival using longitudinal tumor size in non-small cell lung cancer: Approach towards personalized medicine

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20606-e20606

2017

Volltextzugriff (PDF)

Preparing for responsible sharing of clinical trial data

The New England journal of medicine, 2014-01, Vol.370 (5), p.484

2014

Volltextzugriff (PDF)

De-identifying data in clinical trials: an overview or patient de-identitication practices amid the increased push for sharing of clinical data

Applied clinical trials, 2015-08, p.40

2015

Volltextzugriff (PDF)

De-identifying Data in Clinical Trials

Applied clinical trials, 2015-08, Vol.24 (8/9), p.40

2015

Volltextzugriff (PDF)

Abstract B204: A DREAM Challenge to improve prognostic models in patients with metastatic castrate-resistant prostate cancer

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.B204-B204

2015

Volltextzugriff (PDF)

Project Data Sphere initiative: Results from first 6 months of broad access to oncology trials data

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e17691-e17691

2015

Volltextzugriff (PDF)

Building a crowd-sourced challenge using clinical trial data

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e16047-e16047

2015

Volltextzugriff (PDF)

Overcoming barriers to develop a broad access data sharing platform

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e17690-e17690

2015

Volltextzugriff (PDF)

Project data sphere (PDS) in prostate cancer: A first look including concomitant medication use

Journal of clinical oncology, 2015-03, Vol.33 (7_suppl), p.204-204

2015

Volltextzugriff (PDF)

Use of crowdsourced research to develop a prognostic model for first-line metastatic castrate resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.180-180

2016

Volltextzugriff (PDF)

Abstract 3235: The IGF1 inhibitor BMS-754807 synergizes with Lapatinib in colorectal cancer cell lines

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3235-3235

2012

Volltextzugriff (PDF)

CD28-independent induction of experimental autoimmune encephalomyelitis

The Journal of clinical investigation, 2001-03, Vol.107 (5), p.575-583

2001

Volltextzugriff (PDF)

Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis

The Journal of clinical investigation, 2000-04, Vol.105 (8), p.1109-1116

2000

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy

Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data

Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis

Personality diversity in the workplace: A systematic literature review on introversion

Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)

Preparing for Responsible Sharing of Clinical Trial Data

Survival prediction using time-evolving tumor load: An approach to rationally design treatment sequencing, staging, and dosing strategies for oncology combinations

The Prostate Cancer DREAM Challenge: A Community‐Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer

Model-based meta-analysis of safety for immune checkpoint inhibitor combinations and monotherapy

Chronic rejection: Insights from a novel immunosuppressive-free model of kidney transplantation

Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress

Project Data Sphere: A first look at prostate cancer including concomitant medication use, prognosis, and toxicity

Dynamic predictions of patient survival using longitudinal tumor size in non-small cell lung cancer: Approach towards personalized medicine

Preparing for responsible sharing of clinical trial data

De-identifying data in clinical trials: an overview or patient de-identitication practices amid the increased push for sharing of clinical data

De-identifying Data in Clinical Trials

Abstract B204: A DREAM Challenge to improve prognostic models in patients with metastatic castrate-resistant prostate cancer

Project Data Sphere initiative: Results from first 6 months of broad access to oncology trials data

Building a crowd-sourced challenge using clinical trial data

Overcoming barriers to develop a broad access data sharing platform

Project data sphere (PDS) in prostate cancer: A first look including concomitant medication use

Use of crowdsourced research to develop a prognostic model for first-line metastatic castrate resistant prostate cancer (mCRPC)

Abstract 3235: The IGF1 inhibitor BMS-754807 synergizes with Lapatinib in colorectal cancer cell lines

CD28-independent induction of experimental autoimmune encephalomyelitis

Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis

Suchergebnisse filtern